查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1627892

避孕藥市場：預測（2025-2030 年）

Contraceptives Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

避孕藥市場預計將以 6.48% 的複合年成長率成長，從 2025 年的 346.13 億美元成長到 2030 年的 473.86 億美元。

避孕是使用藥物或設備來防止女性懷孕。其他方法通常被稱為生育治療或避孕。隨著性傳染病盛行率的上升，預計市場將繼續成長。越來越多的女性正在尋求避孕藥具和設備，尤其是年輕女性，隨著教育程度的提高，她們開始使用避孕措施。

此外，青少年懷孕帶來的健康風險、人們對現代避孕方法的認知不斷提高以及越來越傾向於將口服避孕藥作為避免意外懷孕的主要方法，這些都可能在未來幾年推動市場成長。

避孕市場促進因素

  • 人口控制需求上升推動避孕市場成長

各國政府為控制人口成長而採取的舉措，提高了都市區婦女的計劃生育和避孕意識。此外，意外懷孕的增加也推動了口服避孕藥的使用增加，尤其是在新興市場。人口正以驚人的速度成長，尤其是在亞洲國家，影響了微觀經濟平衡。公共和私營部門正在共同努力遏制人口成長，性教育和避孕措施將在未來幾年帶來效益。預計這將在預測期內提高口服避孕藥市場的收益。

避孕藥市場的地理概況：

  • 預測期內，北美將呈現指數級成長。

北美市場的成長受到多種因素的推動，包括年輕人對性活動的傾向日益增加以及年輕人對生殖健康和避孕意識的提高。由於廉價非專利產品和設備的普及和使用，該地區的青少年對避孕的需求更大。在美國，公共資助的計劃生育服務不斷擴大，社會組織也加強了提高避孕機會的力道。最重要的是，兩項由政府發起的幫助保險覆蓋避孕措施的措施——《病患保護與平價醫療法案》和《第十條》——使這些產品更容易獲得且更實惠。

為什麼要購買這份報告？

  • 深入分析：深入了解主要地區和新興地區的市場，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他子區隔。
  • 競爭格局：了解全球主要企業所採取的策略策略，並了解正確策略的潛在市場滲透潛力。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力做出策略決策，在動態環境中開闢新的業務流和收益。
  • 受眾廣泛：對於新興企業、研究機構、顧問公司、中小企業和大型企業都有益且具有成本效益。

它有什麼用途？

產業與市場分析、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

  • 2022 年至 2030 年的實際資料和預測
  • 成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
  • 競爭定位、策略與市場佔有率分析
  • 各地區（包括細分市場和國家）的收益成長和預測分析
  • 公司概況（策略、產品、財務、主要發展等）

目錄

第 1 章 簡介

  • 市場概況
  • 市場定義
  • 研究範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 研究過程

第3章執行摘要

  • 主要發現
  • CXO觀點

第4章 市場動態

  • 市場促進因素
  • 市場限制
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第 5 章 避孕藥市場（依產品分類）

  • 介紹
  • 藥物
    • 避孕藥
    • 注射避孕藥
    • 局部避孕藥
    • 裝置
  • 保險套
    • 子宮內避孕器 (IUD)
    • 隔膜
    • 戒指
    • 其他

第 6 章 避孕藥市場通路

  • 介紹
  • 線上
  • 離線

第 7 章 避孕市場（依年齡層）

  • 介紹
  • 15-24歲
  • 25-34歲
  • 35-44歲
  • 年齡 44 歲或以上

8. 避孕藥市場（按地區）

  • 介紹
  • 北美洲
    • 按產品
    • 按分銷管道
    • 按年齡段
    • 按國家
  • 南美洲
    • 按產品
    • 按分銷管道
    • 按年齡段
    • 按國家
  • 歐洲
    • 按產品
    • 按分銷管道
    • 按年齡段
    • 按國家
  • 中東和非洲
    • 按產品
    • 按分銷管道
    • 按年齡段
    • 按國家
  • 亞太地區
    • 按產品
    • 按分銷管道
    • 按年齡段
    • 按國家

第9章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭儀錶板

第10章 公司簡介

  • Allergan plc（AbbVie）
  • ANSELL LTD.
  • Bayer AG
  • CooperSurgical Inc.
  • Merck & Co., Inc.,
  • Church & Dwight Co., Inc.
  • Veru Inc.
  • Mayer Laboratories, Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Reckitt Benckiser Group plc
  • Mankind Pharma
  • Karex Berhad
  • Montage Laboratory
  • Pregna International Ltd.
簡介目錄
Product Code: KSI061613968

The contraceptive market is expected to grow at a CAGR of 6.48%, reaching a market size of US$47.386 billion in 2030 from US$34.613 billion in 2025.

Contraception is the application that prevents a woman from pregnancy through medications or devices. Other commonly known as fertility control and birth control. The market is expected to continue growing as the incidence of STDs rises. More women are seeking contraceptive medicines and devices, particularly among young women who are beginning to use contraception as they attain higher levels of education.

Furthermore, the health risks posed by teenage pregnancy, increased awareness regarding modern contraceptive methods, and a growing preference for oral contraceptives as the principal method to avoid unintended pregnancy are expected to drive market growth over the next few years.

Contraceptive Market Drivers

  • The growing need for population control is contributing to the contraceptive market growth

Government measures to control population growth in various countries have increased awareness of family planning and contraception among women in both rural and urban areas. Additionally, rising incidences of unintended pregnancies have led to increased utilization of oral contraceptives, especially in developed markets. Particularly in Asian countries, the population is expanding at an incredible rate, impacting the microeconomic balance. The public and private sectors are working together to control this growing population, which should benefit sex education and the use of contraceptives in the years to come. This is expected to drive the market revenue for oral contraceptives during the forecast period.

Contraceptive Market Geographical Outlook:

  • North America is witnessing exponential growth during the forecast period.

The market growth in North America includes the inclination of young people toward sexual activities and the high awareness of reproductive health and contraception among them regarding the matters. Teenagers in the regions need contraceptives more due to the introduction and spread of cheap generic products and devices. The expansion of publicly funded family planning services and the rise in social organization efforts in the US to increase access to contraception. Most importantly, the two government-aided initiatives where insurance covers contraceptive methods- the Affordable Care Act and Title X- have made these products accessible and affordable.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The contraceptive market is segmented and analyzed as follows:

By Product

  • Drugs
  • Contraceptive Pills
  • Injectable Contraceptives
  • Topical Contraceptives
  • Devices
  • Condoms
  • Intrauterine Devices (IUDs)
  • Diaphragms
  • Rings
  • Others

By Distribution Channel

  • Online
  • Offline

By Age Group

  • 15-24 years
  • 25-34 years
  • 35-44 years
  • Above 44 years

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. CONTRACEPTIVE MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Drugs
    • 5.2.1. Contraceptive Pills
    • 5.2.2. Injectable Contraceptives
    • 5.2.3. Topical Contraceptives
    • 5.2.4. Devices
  • 5.3. Condoms
    • 5.3.1. Intrauterine Devices (IUDs)
    • 5.3.2. Diaphragms
    • 5.3.3. Rings
    • 5.3.4. Others

6. CONTRACEPTIVE MARKET BY DISTRIBUTIIN CHANNEL

  • 6.1. Introduction
  • 6.2. Online
  • 6.3. Offline

7. CONTRACEPTIVE MARKET BY AGE GROUP

  • 7.1. Introduction
  • 7.2. 15-24 years
  • 7.3. 25-34 years
  • 7.4. 35-44 years
  • 7.5. Above 44 years

8. CONTRACEPTIVE MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product
    • 8.2.2. By Distribution Channel
    • 8.2.3. By Age Group
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Product
    • 8.3.2. By Distribution Channel
    • 8.3.3. By Age Group
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Product
    • 8.4.2. By Distribution Channel
    • 8.4.3. By Age Group
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Italy
      • 8.4.4.5. Spain
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Product
    • 8.5.2. By Distribution Channel
    • 8.5.3. By Age Group
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Product
    • 8.6.2. By Distribution Channel
    • 8.6.3. By Age Group
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Taiwan
      • 8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Allergan plc (AbbVie)
  • 10.2. ANSELL LTD.
  • 10.3. Bayer AG
  • 10.4. CooperSurgical Inc.
  • 10.5. Merck & Co., Inc.,
  • 10.6. Church & Dwight Co., Inc.
  • 10.7. Veru Inc.
  • 10.8. Mayer Laboratories, Inc.
  • 10.9. Pfizer Inc.
  • 10.10. Teva Pharmaceutical Industries Ltd.
  • 10.11. Reckitt Benckiser Group plc
  • 10.12. Mankind Pharma
  • 10.13. Karex Berhad
  • 10.14. Montage Laboratory
  • 10.15. Pregna International Ltd.